较慢与较快静脉液体推注速率对危重患者死亡率的影响:BaSICS随机临床试验
IMPORTANCE: Slower intravenous fluid infusion rates could reduce the formation of tissue edema and organ dysfunction in critically ill patients; however, there are no data to support different infusion rates during fluid challenges for important outcomes such as mortality.…
要点
- 危重患者液体挑战时,慢速输注(333 mL/h)较对照速率(999 mL/h)未改善90天生存。
核心结论
- 在需液体挑战的ICU患者中,较慢输注速率相比更快速率未降低90天死亡率,结果不支持采用更慢的输注速率。
研究设计与样本
- 患者随机接受慢速(333 mL/h,n=5538)或对照速率(999 mL/h,n=5514)液体挑战,同时按析因设计随机接受平衡液或0.9%氯化钠。
主要发现
- 慢速组首日平均输注1162 mL,对照组为1252 mL。
- 90天时慢速组5276例中死亡1406例(26.6%),对照组5244例中死亡1414例(27.0%)。
临床怎么用
- 对ICU需液体挑战的患者,无需以改善90天生存为目的刻意采用更慢的静脉输注速率。
局限性
- 研究为非盲设计。
- 分析排除了重复随机和撤回同意的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Slower intravenous fluid infusion rates could reduce the formation of tissue edema and organ dysfunction in critically ill patients; however, there are no data to support different infusion rates during fluid challenges for important outcomes such as mortality. OBJECTIVE: To determine the effect of a slower infusion rate vs control infusion rate on 90-day survival in patients in the intensive care unit (ICU). DESIGN, SETTING, AND PARTICIPANTS: Unblinded randomized factorial clinical trial in 75 ICUs in Brazil, involving 11 052 patients requiring at least 1 fluid challenge and with 1 risk factor for worse outcomes were randomized from May 29, 2017, to March 2, 2020. Follow-up was concluded on October 29, 2020. Patients were randomized to 2 different infusion rates (reported in this article) and 2 different fluid types (balanced fluids or saline, reported separately). INTERVENTIONS: Patients were randomized to receive fluid challenges at 2 different infusion rates; 5538 to the slower rate (333 mL/h) and 5514 to the control group (999 mL/h). Patients were also randomized to receive balanced solution or 0.9% saline using a factorial design. MAIN OUTCOMES AND MEASURES: The primary end point was 90-day survival. RESULTS: Of all randomized patients, 10 520 (95.2%) were analyzed (mean age, 61.1 years [SD, 17.0 years]; 44.2% were women) after excluding duplicates and consent withdrawals. Patients assigned to the slower rate received a mean of 1162 mL on the first day vs 1252 mL for the control group. By day 90, 1406 of 5276 patients (26.6%) in the slower rate group had died vs 1414 of 5244 (27.0%) in the control group (adjusted hazard ratio, 1.03; 95% CI, 0.96-1.11; P = .46). There was no significant interaction between fluid type and infusion rate (P = .98). CONCLUSIONS AND RELEVANCE: Among patients in the intensive care unit requiring fluid challenges, infusing at a slower rate compared with a faster rate did not reduce 90-day mortality. These findings do not support the use of a slower infusion rate. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02875873.
引用
- Zampieri FG, Machado FR, Biondi RS, et al. Effect of Slower vs Faster Intravenous Fluid Bolus Rates on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical Trial. JAMA. 2021. PMID: 34547081. doi:10.1001/jama.2021.11444
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。